Dissecting the host response to a gamma-herpesvirus
- PMID: 11313013
- PMCID: PMC1088446
- DOI: 10.1098/rstb.2000.0786
Dissecting the host response to a gamma-herpesvirus
Abstract
The murine gamma-herpesvirus 68 (MHV-68) provides a unique experimental model for dissecting immunity to large DNA viruses that persist in B lymphocytes. The analysis is greatly facilitated by the availability of genetically disrupted (-/-) mice that lack key host-response elements, and by the fact that MHV-68 is a lytic virus that can readily be manipulated for mutational analysis. The mutant virus strategy is being used, for example, to characterize the part played in vivo by an MHV-68-encoded chemokine-binding protein that may ultimately find an application in human therapeutics. Experiments with various -/- mice and monoclonal antibody depletion protocols have shown very clearly that type I interferons (IFNs) are essential for the early control of MHV-68 replication, while CD4+ T cells producing IFN-gamma function to limit the consequences of viral persistence. Virus-specific CD8+ effectors acting in the absence of the CD4+ subset seem initially to control the lytic phase in the lung following respiratory challenge, but are then unable to prevent the reactivation of replicative infection in epithelia and the eventual death of CD4+ T-cell-deficient mice. This could reflect the fact that the interaction between the CD8+ T cells and the virus-infected targets is partially compromised by the MHV-68 K3 protein, which inhibits antigen presentation by MHC class I glycoproteins. Immunization strategies focusing on the CD8+ T-cell response to epitopes expressed during the lytic phase of MHV-68 infection can limit virus replication, but are unable to prevent the establishment of latency. Other experiments with mutant viruses also suggest that there is a disconnection between lytic MHV-68 infection and latency. The massive nonspecific immunoglobulin response and the dramatic expansion of Vbeta4+ CD8+ T cells, which is apparently MHC independent, could represent some sort of 'smoke screen' used by MHV-68 to subvert immunity. Although MHV-68 is neither Epstein-Barr virus nor human herpesvirus-8, the results generated from this system suggest possibilities that may usefully be addressed with these human pathogens. Perhaps the main lesson learned to date is that all the components of immunity are likely to be important for the control of these complex viruses.
Similar articles
-
Natural history of murine gamma-herpesvirus infection.Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):569-79. doi: 10.1098/rstb.2000.0779. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11313012 Free PMC article. Review.
-
MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.Vaccine. 2011 May 23;29(23):3935-44. doi: 10.1016/j.vaccine.2011.03.092. Epub 2011 Apr 8. Vaccine. 2011. PMID: 21481326
-
Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68.J Immunol. 2015 Mar 15;194(6):2746-56. doi: 10.4049/jimmunol.1401928. Epub 2015 Feb 6. J Immunol. 2015. PMID: 25662997 Free PMC article.
-
Reduced functional capacity of CD8+ T cells expanded by post-exposure vaccination of gamma-herpesvirus-infected CD4-deficient mice.J Immunol. 2002 Apr 1;168(7):3477-83. doi: 10.4049/jimmunol.168.7.3477. J Immunol. 2002. PMID: 11907108
-
Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections.Acta Microbiol Immunol Hung. 2005;52(1):41-71. doi: 10.1556/AMicr.52.2005.1.2. Acta Microbiol Immunol Hung. 2005. PMID: 15957234 Review.
Cited by
-
Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host.Front Microbiol. 2016 Aug 17;7:1202. doi: 10.3389/fmicb.2016.01202. eCollection 2016. Front Microbiol. 2016. PMID: 27582728 Free PMC article. Review.
-
Immune regulation of viral infection and vice versa.Immunol Res. 2005;32(1-3):293-315. doi: 10.1385/IR:32:1-3:293. Immunol Res. 2005. PMID: 16106080 Review.
-
Effective vaccination against long-term gammaherpesvirus latency.J Virol. 2003 Feb;77(4):2522-9. doi: 10.1128/jvi.77.4.2522-2529.2003. J Virol. 2003. PMID: 12551990 Free PMC article.
-
Different functional capacities of latent and lytic antigen-specific CD8 T cells in murine gammaherpesvirus infection.J Immunol. 2004 Jan 15;172(2):1213-9. doi: 10.4049/jimmunol.172.2.1213. J Immunol. 2004. PMID: 14707099 Free PMC article.
-
Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo.J Virol. 2008 Dec;82(24):12498-509. doi: 10.1128/JVI.01152-08. Epub 2008 Oct 8. J Virol. 2008. PMID: 18842717 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials